Donor-derived ex-vivo expanded natural killer cell infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived ex-vivo expanded natural killer cell infusion, covering 2025-05-04 to 2025-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant [Phase 2]